APA (7th ed.) Citation

Bao D. Dao MD, Ildiko Lingvay MD, M., Joseph Sailors MD, Michael Landay MD, & Gabriel Shapiro MD, F. (2015). First-Line Use of Vemurafenib to Enable Thyroidectomy and Radioactive Iodine Ablation for BRAF-Positive Metastatic Papillary Thyroid Carcinoma. SAGE Publishing.

Chicago Style (17th ed.) Citation

Bao D. Dao MD, MPH Ildiko Lingvay MD, Joseph Sailors MD, Michael Landay MD, and FACP Gabriel Shapiro MD. First-Line Use of Vemurafenib to Enable Thyroidectomy and Radioactive Iodine Ablation for BRAF-Positive Metastatic Papillary Thyroid Carcinoma. SAGE Publishing, 2015.

MLA (9th ed.) Citation

Bao D. Dao MD, et al. First-Line Use of Vemurafenib to Enable Thyroidectomy and Radioactive Iodine Ablation for BRAF-Positive Metastatic Papillary Thyroid Carcinoma. SAGE Publishing, 2015.